A carregar...

Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study

BACKGROUND: With advancement in the treatment options of rheumatoid arthritis (RA), optimising the outcomes of difficult-to-treat patients has become increasingly important in clinical practice. In particular, insensitivity to first-line biologic disease-modifying anti-rheumatic drugs (bDMARD) is be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Ochi, Sae, Saito, Kazuyoshi, Mizoguchi, Fumitaka, Kato, Shigeaki, Tanaka, Yoshiya
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057565/
https://ncbi.nlm.nih.gov/pubmed/32131890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-2122-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!